Literature DB >> 19342235

Further evidence of Fukutin mutations as a cause of childhood onset limb-girdle muscular dystrophy without mental retardation.

Rebecca L Puckett1, Steven A Moore, Thomas L Winder, Tobias Willer, Stephen G Romansky, Kelly King Covault, Kevin P Campbell, Jose E Abdenur.   

Abstract

The dystroglycanopathies comprise a clinically and genetically heterogeneous group of muscular dystrophies characterized by deficient glycosylation of alpha-dystroglycan. Mutations in the fukutin (FKTN) gene have primarily been identified among patients with classic Fukuyama congenital muscular dystrophy (FCMD), a severe form of dystroglycanopathy characterized by CMD, cobblestone lissencephaly and ocular defects. We describe two brothers of Caucasian and Japanese ancestry with normal intelligence and limb-girdle muscular dystrophy (LGMD) due to compound heterozygous FKTN mutations. Muscle biopsy showed a dystrophy with selectively reduced alpha-dystroglycan glycoepitope immunostaining. Immunoblots revealed hypoglycosylation of alpha-dystroglycan and loss of laminin binding. FKTN gene sequencing identified two variants: c.340G>A and c.527T>C, predicting missense mutations p.A114T and p.F176S, respectively. Our results provide further evidence for ethnic and allelic heterogeneity and the presence of milder phenotypes in FKTN-dystroglycanopathy despite a substantial degree of alpha-dystroglycan hypoglycosylation in skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19342235      PMCID: PMC2698593          DOI: 10.1016/j.nmd.2009.03.001

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  30 in total

1.  A homozygous nonsense mutation in the fukutin gene causes a Walker-Warburg syndrome phenotype.

Authors:  D Beltrán-Valero de Bernabé; H van Bokhoven; E van Beusekom; W Van den Akker; S Kant; W B Dobyns; B Cormand; S Currier; B Hamel; B Talim; H Topaloglu; H G Brunner
Journal:  J Med Genet       Date:  2003-11       Impact factor: 6.318

Review 2.  Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function.

Authors:  Daniel E Michele; Kevin P Campbell
Journal:  J Biol Chem       Date:  2003-01-29       Impact factor: 5.157

3.  Clinicopathological study on eyes from cases of Fukuyama type congenital muscular dystrophy.

Authors:  N Hino; M Kobayashi; N Shibata; T Yamamoto; K Saito; M Osawa
Journal:  Brain Dev       Date:  2001-03       Impact factor: 1.961

4.  Structural organization, complete genomic sequences and mutational analyses of the Fukuyama-type congenital muscular dystrophy gene, fukutin.

Authors:  K Kobayashi; J Sasaki; E Kondo-Iida; Y Fukuda; M Kinoshita; Y Sunada; Y Nakamura; T Toda
Journal:  FEBS Lett       Date:  2001-02-02       Impact factor: 4.124

5.  Understanding human disease mutations through the use of interspecific genetic variation.

Authors:  M P Miller; S Kumar
Journal:  Hum Mol Genet       Date:  2001-10-01       Impact factor: 6.150

6.  Haplotype-phenotype correlation in Fukuyama congenital muscular dystrophy.

Authors:  K Saito; M Osawa; Z P Wang; K Ikeya; Y Fukuyama; E Kondo-Iida; T Toda; H Ohashi; K Kurosawa; S Wakai; K Kaneko
Journal:  Am J Med Genet       Date:  2000-05-29

7.  Congenital progressive muscular dystrophy of the Fukuyama type - clinical, genetic and pathological considerations.

Authors:  Y Fukuyama; M Osawa; H Suzuki
Journal:  Brain Dev       Date:  1981       Impact factor: 1.961

8.  Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies.

Authors:  Daniel E Michele; Rita Barresi; Motoi Kanagawa; Fumiaki Saito; Ronald D Cohn; Jakob S Satz; James Dollar; Ichizo Nishino; Richard I Kelley; Hannu Somer; Volker Straub; Katherine D Mathews; Steven A Moore; Kevin P Campbell
Journal:  Nature       Date:  2002-07-25       Impact factor: 49.962

9.  Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan.

Authors:  Cheryl Longman; Martin Brockington; Silvia Torelli; Cecilia Jimenez-Mallebrera; Colin Kennedy; Nofal Khalil; Lucy Feng; Ravindra K Saran; Thomas Voit; Luciano Merlini; Caroline A Sewry; Susan C Brown; Francesco Muntoni
Journal:  Hum Mol Genet       Date:  2003-09-09       Impact factor: 6.150

10.  POMT1 mutation results in defective glycosylation and loss of laminin-binding activity in alpha-DG.

Authors:  D S Kim; Y K Hayashi; H Matsumoto; M Ogawa; S Noguchi; N Murakami; R Sakuta; M Mochizuki; D E Michele; K P Campbell; I Nonaka; I Nishino
Journal:  Neurology       Date:  2004-03-23       Impact factor: 9.910

View more
  6 in total

1.  The zebrafish dag1 mutant: a novel genetic model for dystroglycanopathies.

Authors:  Vandana Gupta; Genri Kawahara; Stacey R Gundry; Aye T Chen; Wayne I Lencer; Yi Zhou; Leonard I Zon; Louis M Kunkel; Alan H Beggs
Journal:  Hum Mol Genet       Date:  2011-02-04       Impact factor: 6.150

2.  Compound Heterozygous FKTN Variants in a Patient with Dilated Cardiomyopathy Led to an Aberrant α-Dystroglycan Pattern.

Authors:  Anna Gaertner; Lidia Burr; Baerbel Klauke; Andreas Brodehl; Kai Thorsten Laser; Karin Klingel; Jens Tiesmeier; Uwe Schulz; Edzard Zu Knyphausen; Jan Gummert; Hendrik Milting
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

3.  Novel mutation in the fukutin gene in an Egyptian family with Fukuyama congenital muscular dystrophy and microcephaly.

Authors:  Samira Ismail; Ashleigh E Schaffer; Rasim O Rosti; Joseph G Gleeson; Maha S Zaki
Journal:  Gene       Date:  2014-02-13       Impact factor: 3.688

Review 4.  Genetic basis of limb-girdle muscular dystrophies: the 2014 update.

Authors:  Vincenzo Nigro; Marco Savarese
Journal:  Acta Myol       Date:  2014-05

5.  Novel fukutin mutations in limb-girdle muscular dystrophy type 2M with childhood onset.

Authors:  Mateja Smogavec; Jana Zschüntzsch; Wolfram Kress; Julia Mohr; Peter Hellen; Barbara Zoll; Silke Pauli; Jens Schmidt
Journal:  Neurol Genet       Date:  2017-07-10

6.  Congenital protein hypoglycosylation diseases.

Authors:  Susan E Sparks
Journal:  Appl Clin Genet       Date:  2012-07-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.